Journal article

Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?

Mushfiq H Shaikh, Daniel TW Clarke, Newell W Johnson, Nigel AJ McMillan

Oral Oncology | ELSEVIER | Published : 2017

DOI: 10.1016/j.oraloncology.2017.02.016

University of Melbourne Researchers

Grants

Funding Acknowledgements

MHS is funded by Griffith University, Australia. NAJM has received funding from the Cancer Council of Queensland and the National Health and Medical Research Council of Australia.

Citation metrics

5Web of Science
5Scopus
5Dimensions

Keywords

Gene Editing
Human-Papillomavirus
In-Vitro
Photodynamic Therapy
Carcinoma, Squamous Cell
Squamous-Cell Carcinoma
Science & Technology
Dentistry, Oral Surgery & Medicine
Human Papillomavirus
Short Interfering Rna
Small Interfering Rna
Head and Neck Squamous Cell Carcinoma
Factor Receptor Egfr
Nf-Kappa-B
Head and Neck Neoplasms
Rna Interference
Gene Silencing
Systemic Delivery
Oncology
Crispr/cas
Squamous Cell Carcinoma of Head and Neck
Sirna Delivery
Life Sciences & Biomedicine
Nanoparticles and Lipoplex
Drug-Delivery
Humans